Prosight Management’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,815,652	Closed	-$6.28M	–	40
2025 Q1	$6.28M	Sell	2,815,652 -4,534,348	-62%	-$13M	2.06%	20
2024 Q4	$21.5M	Sell	7,350,000 -1,729,539	-19%	-$4.82M	6.03%	5
2024 Q3	$23.6M	Buy	9,079,539 +6,726,906	+286%	+$18.6M	5.99%	4
2024 Q2	$6.96M	Buy	2,352,633 +562,633	+31%	+$2.13M	2.08%	16
2024 Q1	$8.11M	Buy	1,790,000 +90,000	+5%	+$459K	2.26%	14
2023 Q4	$9.71M	Sell	1,700,000 -746,000	-30%	-$3.46M	4.04%	9
2023 Q3	$11.3M	Sell	2,446,000 -104,000	-4%	-$633K	3.57%	9
2023 Q2	$16.5M	Buy	2,550,000 +1,796,472	+238%	+$12.3M	4.82%	8
2023 Q1	$5.68M	Buy	753,528 +430,774	+133%	+$3.91M	2.72%	16
2022 Q4	$3.27M	Buy	322,754 +236,250	+273%	+$2.73M	1.83%	19
2022 Q3	$856K	Buy	+86,504	New	+$949K	0.47%	35